vol. 64 October 2025

KOBE Biomedical Innovation Cluster newsletter vol. 64
- October 2025 -

Hello,

KBIC exhibited at BioJapan 2025, held at Pacifico Yokohama from Wednesday October 8 to Friday October 10, 2025. BioJapan is one of Asia's largest biotechnology partnering events, attracting numerous participants from the pharmaceutical industry, biotech companies, academia, and research institutions both in Japan and overseas. The event facilitated active networking, business meetings, and presentations of cutting-edge technologies and research achievements.

At our booth, we showcased the strengths of KBIC ecosystem by exhibiting together with 4 KBIC companies: MiCAN Technologies Inc., Trans Genic Inc., Cyto-Facto Inc., and Matrixome Inc. The booth featured a wide range of technologies and products related to regenerative medicine, drug discovery, gene therapy, cell manufacturing, and cell culture, drawing significant interest from visitors.

We also focused on utilizing the business matching system, which enabled us to conduct many pre-arranged business meetings. This allowed for efficient information exchange and partner discovery within a limited timeframe, leading to promising new opportunities for collaboration. By leveraging the connections and insights gained through BioJapan, we will continue to strengthen our support for the global expansion of KBIC-affiliated companies.

We would like to extend our sincere gratitude to all those who visited our booth and to everyone who participated in the meetings. We will see you all again next year!

FBRI Editorial Team

NEWS

Call for Participants!! Regenerative Medicine Industrialization Forum 2026 in Nihonbashi – Toward the Growth of Regenerative Medicine as an Industry –

The Foundation for Biomedical Research and Innovation at Kobe (FBRI), which promotes regenerative medicine and its development as an industry, will host the “Regenerative Medicine Industrialization Forum 2026 in Nihonbashi” in cooperation with Kobe City. The event will take place on Tuesday, February 10, 2026, in Nihonbashi, Tokyo, with the aim of sharing challenges among companies and research institutions and strengthening collaboration.

Now in its 9th year, this forum will be held under the theme "Toward the Growth of Regenerative Medicine as an Industry." Experts from academia, industry, and the Ministry of Health, Labour and Welfare will be invited to present the latest developments in the field of regenerative medicine and the broader healthcare industry, both in Japan and internationally.

In addition, a panel discussion will be held featuring leading professionals from academia, industry, and government to engage in an in-depth dialogue on the challenges and future prospects of industrializing regenerative medicine from diverse perspectives.

We look forward to your participation!

Collaboration Between Minaris Advanced Therapies and Healios for the Commercial Manufacturing of Invimestrocel (Published: October 7, 2025)

On August 21st, Kobe Biomedical Innovation Cluster (KBIC) welcomed a business delegation centered around Taipei City, Taiwan. On that day, an MOU was signed between Century Biotech Development Company (CBDC) and Foundation for Biomedical Research and Innovation at Kobe (FBRI), with the aim to support companies from both clusters that are interested in expanding into Japan and Taiwan, jointly provide opportunities for interaction between companies and stakeholders from both clusters, and create new business opportunities.
Both parties will continue to exchange information and provide updates on business expansion support programs, useful information and specific action plans to promote continued mutual collaboration.